High drug related mortality rates following prison release: Assessing the acceptance likelihood of a naltrexone injection and related concerns. Murphy PN, Mohammed F, Wareing M, Cotton A, McNeill J, Irving P, Jones S, Sharples L, Monk R, Elton P…

Naltrexone Excerpt: Limited data indicate that naltrexone is minimally excreted into breastmilk. If naltrexone is required by the mother, it is not a reason to discontinue breastfeeding. Sections - Drug Levels and Effects - Substance Identificat…

Naltrexon (Naltrexin®) Naltrexon eignet sich für ein kleines Segment hochmotivierter entgifteter opioidabhängiger Patienten, ohne aktuellen Opioidkonsum (weder im Rahmen einer SGB oder als illegaler Konsum). Polytoxikomanie ist eine K…

Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands. Zaaijer ER, Goudriaan AE, Koeter MW, Booij J, van den Brink W. Subst Use Misuse. 2016 Dec 5;51(14):1905-11. doi: 10.108…

Effectiveness, safety and feasibility of extended release naltrexone for opioid dependence: a nine month follow up to a three month randomized trial. Solli, K. K., Latif, Z., Opheim, A., Krajci, P., Sharma‐Haase, K., Benth, Jė. Š., Tanum, L…

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA. Drug…